Coburger Jan, Hagel Vincent, Wirtz Christian Rainer, König Ralph
Department of Neurosurgery, Campus Günzburg, University of Ulm, Ludwig Heilmeyerstr. 2, Günzburg, Germany.
PLoS One. 2015 Jun 26;10(6):e0131872. doi: 10.1371/journal.pone.0131872. eCollection 2015.
There is rising evidence that in glioblastoma (GBM) surgery an increase of extent of resection (EoR) leads to an increase of patient's survival. Based on histopathological assessments tumor depiction of Gd-DTPA enhancement and 5-aminolevulinic-acid-fluorescence (5-ALA) might be synergistic for intraoperative resection control.
To assess impact of additional use of 5-ALA in intraoperative MRI (iMRI) assisted surgery of GBMs on extent of resection (EoR), progression free survival (PFS) and overall survival (OS).
We prospectively enrolled 33 patients with GBMs eligible for gross-total-resection(GTR) and performed a combined approach using 5-ALA and iMRI. As a control group, we performed a retrospective matched pair assessment, based on 144 patients with iMRI-assisted surgery. Matching criteria were, MGMT promotor methylation, recurrent surgery, eloquent location, tumor size and age. Only patients with an intended GTR and primary GBMs were included. We calculated Kaplan Mayer estimates to compare OS and PFS using the Log-Rank-Test. We used the T-test to compare volumetric results of EoR and the Chi-Square-Test to compare new permanent neurological deficits (nPND) and general complications between the two groups.
Median follow up was 31 months. No significant differences between both groups were found concerning the matching criteria. GTR was achieved significantly more often (p <0.010) using 5-ALA&iMRI (100%) compared to iMRI alone (82%). Mean EoR was significantly (p<0.004) higher in 5-ALA&iMRI-group (99.7%) than in iMRI-alone-group (97.4%) Rate of complications did not differ significantly between groups (21% iMRI-group, 27%5-ALA&iMRI-group, p<0.518). nPND were found in 6% in both groups. Median PFS (6 mo resp.; p<0.309) and median OS (iMRI:17 mo; 5-ALA&iMRI-group: 18 mo; p<0.708)) were not significantly different between both groups.
We found a significant increase of EoR when combining 5-ALA&iMRI compared to use of iMRI alone. Maximizing EoR did not lead to an increase of complications or neurological deficits if used with neurophysiological monitoring in eloquent lesions. No final conclusion can be drawn whether a further increase of EoR benefits patient's progression free survival and overall survival.
越来越多的证据表明,在胶质母细胞瘤(GBM)手术中,切除范围(EoR)的增加会提高患者的生存率。基于组织病理学评估,钆喷酸葡胺(Gd-DTPA)增强和5-氨基酮戊酸荧光(5-ALA)对肿瘤的描绘可能在术中切除控制方面具有协同作用。
评估在GBM的术中磁共振成像(iMRI)辅助手术中额外使用5-ALA对切除范围(EoR)、无进展生存期(PFS)和总生存期(OS)的影响。
我们前瞻性纳入了33例适合进行全切除(GTR)的GBM患者,并采用5-ALA和iMRI联合方法。作为对照组,我们基于144例接受iMRI辅助手术的患者进行了回顾性配对评估。配对标准为O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化、再次手术、功能区位置、肿瘤大小和年龄。仅纳入预期进行GTR且为原发性GBM的患者。我们使用对数秩检验计算Kaplan-Meier估计值以比较OS和PFS。我们使用t检验比较EoR的体积结果,并使用卡方检验比较两组之间新出现的永久性神经功能缺损(nPND)和一般并发症。
中位随访时间为31个月。两组在配对标准方面未发现显著差异。与单独使用iMRI(82%)相比,使用5-ALA&iMRI时实现GTR的比例显著更高(p<0.010)(100%)。5-ALA&iMRI组的平均EoR(99.7%)显著高于单独使用iMRI组(97.4%)(p<0.004)。两组之间的并发症发生率无显著差异(iMRI组为21%,5-ALA&iMRI组为27%,p<0.518)。两组中nPND的发生率均为6%。两组之间的中位PFS(分别为6个月;p<0.309)和中位OS(iMRI组:17个月;5-ALA&iMRI组:18个月;p<0.708)无显著差异。
我们发现,与单独使用iMRI相比,联合使用5-ALA&iMRI时EoR显著增加。在功能区病变中使用神经生理监测的情况下,将EoR最大化不会导致并发症或神经功能缺损增加。关于EoR的进一步增加是否有益于患者的无进展生存期和总生存期,目前尚无最终结论。